Cortex Pharmaceuticals, Inc. Receives Funding from The Michael J. Fox Foundation to Discover Drug Candidates for Parkinson’s Disease

IRVINE, Calif.--(BUSINESS WIRE)--Cortex Pharmaceuticals, Inc. (OTCBB: CORX) announced that it has been awarded a grant by The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to test selected compounds from its AMPAKINE® platform for their ability to restore brain function in animal models of Parkinson’s disease.
MORE ON THIS TOPIC